Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Common Stock | Options Exercise | $42.5K | +6K | +9.74% | $7.09 | 67.6K | Mar 3, 2023 | Direct | F1 |
transaction | EVRI | Common Stock | Sale | -$111K | -6K | -8.88% | $18.58 | 61.6K | Mar 3, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Stock Option | Options Exercise | -$42.5K | -6K | -100% | $7.09 | 0 | Mar 3, 2023 | Common Stock | 6K | $7.09 | Direct | F3 |
Id | Content |
---|---|
F1 | The transactions reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on September 10, 2021 and amended on May 18, 2022 for options originally granted on March 6, 2013 that would have expired on March 6, 2023. |
F2 | The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $18.50 to $18.76. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | Represents an option to purchase 19,424 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant of March 6, 2013. |